Metastatic Colorectal Cancers Active Not Recruiting Phase 2 Trials for Panitumumab (DB01269)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03142516FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance StatusTreatment
NCT03164655SULTAN (Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network)Treatment
NCT01328171FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)Treatment
NCT01801904A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal CancerTreatment